Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture
2010-024327-24Phase 2Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of C1 inhibitor, human in Systemic Inflammatory Response Syndrome (SIRS), sepsis, acute respiratory distress syndrome (ARDS) and 1 more (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Change in interleukin-6 after surgical repair. Started Jan 2011; status: terminated.
02
Drugs
C1 inhibitor, human
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)sepsisacute respiratory distress syndrome (ARDS)multiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on 2010-024327-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024327-24.